GEOFFREY MACKAY

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Mary Kay Fenton, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GEOFFREY MACKAY:

Company Role Class Num Shares Value Price $ Report Date Ownership
AVROBIO, Inc. President & CEO, Director Common Stock 445,123 $536,373 $1.20 28 Dec 2022 By The Geoff R. MacKay Irrevocable Trust
AVROBIO, Inc. President & CEO, Director Restricted Stock Unit 300,667 $360,981 $1.20 08 Feb 2023 Direct
AVROBIO, Inc. President & CEO, Director Common Stock 188,012 $226,554 $1.20 24 Jan 2023 Direct
AVROBIO, Inc. President & CEO, Director Common Stock 72,604 $87,488 $1.20 28 Dec 2022 By daughter of reporting person
AVROBIO, Inc. President & CEO, Director Common Stock 72,604 $87,488 $1.20 28 Dec 2022 By son of reporting person
Talaris Therapeutics, Inc. Director Stock Option (Right to Buy) 20,500 13 Jun 2023 Direct
AVROBIO, Inc. President & CEO, Director Stock Option (Right to Buy) 0 24 Jan 2023 Direct

Insider Reports Filed by GEOFFREY MACKAY

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRML Talaris Therapeutics, Inc. 13 Jun 2023 1 $0 4 Director 14 Jun 2023, 18:59
TECX AVROBIO, Inc. 08 Feb 2023 1 $0 4 President & CEO, Director 10 Feb 2023, 16:08
TECX AVROBIO, Inc. 28 Dec 2022 4 +$41,859 4 President & CEO, Director 26 Jan 2023, 16:30
TECX AVROBIO, Inc. 23 Dec 2022 2 +$58,680 4 President & CEO, Director 28 Dec 2022, 18:18
TECX AVROBIO, Inc. 08 Dec 2022 1 $0 4 President & CEO, Director 09 Dec 2022, 16:30
TRML Talaris Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 18:15
TECX AVROBIO, Inc. 02 Feb 2022 2 $0 4 President & CEO, Director 04 Feb 2022, 16:22
TECX AVROBIO, Inc. 10 Jun 2021 1 $0 4 President & CEO, Director 14 Jun 2021, 17:58